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The gamma interferon (IFN-)-activated inhibitor of translation (GAIT) complex in humanmyeloid cells is heterotetrameric,
consisting of glutamyl-prolyl-tRNA synthetase (EPRS), NS1-associated protein 1 (NSAP1), ribosomal protein L13a, and glyceral-
dehyde-3-phosphate dehydrogenase (GAPDH). The complex binds a structural GAIT element in the 3= untranslated region of
VEGF-A and other inflammation-related transcripts and inhibits their translation. EPRS is dually phosphorylated by cyclin-de-
pendent kinase 5 (Cdk5) at Ser886 and then by a Cdk5-dependent-AGC kinase at Ser999; L13a is phosphorylated at Ser77 by death-
associated protein kinases DAPK and ZIPK. Because profound differences in inflammatory responses betweenmice and humans
are known, we investigated the GAIT system inmouse macrophages. The murine GAIT complex is heterotrimeric, lacking
NSAP1. As in humans, IFN- activates the mouse macrophage GAIT system via induced phosphorylation of EPRS and L13a. Mu-
rine L13a is phosphorylated at Ser77 by the DAPK-ZIPK cascade, but EPRS is phosphorylated only at Ser999. Loss of EPRS Ser886
phosphorylation prevents NSAP1 incorporation into the GAIT complex. However, the triad of Ser999-phosphorylated EPRS,
Ser77-phosphorylated L13a, and GAPDH forms a functional GAIT complex that inhibits translation of GAIT target mRNAs.
Thus, translational control by the heterotrimeric GAIT complex in mice exemplifies the distinctive species-specific responses of
myeloid cells to inflammatory stimuli.
Transcript-selective translation inhibition is an important post-transcriptional mechanism to regulate gene expression. It is
generally mediated by the binding of a protein or complex (or
noncodingRNA) to specific sequence or structural elements in the
5= or 3= untranslated region (UTR) (8, 44). 3= UTR-specific post-
transcriptional mechanisms are particularly critical in regulating
the expression of genes associated with inflammation (22, 26). In
human myeloid cells, the inflammatory cytokine gamma inter-
feron (IFN-) induces the formation of a heterotetrameric, IFN-
-activated inhibitor of translation (GAIT) complex that binds a
defined, split stem-loop GAIT element in the 3= UTR of multiple
inflammation-related mRNAs and inhibits their translation (26).
Among the targets are vascular endothelial growth factor A
(VEGF-A), ceruloplasmin (Cp), death-associated protein kinases
DAPK and ZIPK, and several chemokines and their receptors (26,
43). The human GAIT complex is heterotetrameric, consisting of
glutamyl-prolyl-tRNA synthetase (EPRS), NS1-associated pro-
tein 1 (NSAP1), ribosomal protein L13a, and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) (37).
Recruitment of the four GAIT proteins and their assembly into
GAIT complex is regulated by a network of IFN--activated ki-
nases. The human GAIT complex is assembled in two distinct
stages. After about 2 to 4 h of IFN- treatment, EPRS is phosphor-
ylated at two sites, first at Ser886 by cyclin-dependent kinase 5
(Cdk5) and subsequently at Ser999 by a Cdk5-dependent AGC
kinase (2, 3). Both phosphorylation events occur in the noncata-
lytic linker domain that joins the functional ERS and PRS synthe-
tases. Two-site Ser phosphorylation induces the release of EPRS
from its residence in the tRNA multisynthetase complex (MSC).
Free, phosphorylated EPRS binds NSAP1 to form the nonfunc-
tional pre-GAIT complex that does not bind GAIT element RNA;
EPRS Ser886 phosphorylation is essential for NSAP1 interaction.
About 12 to 16 h later, ribosomal protein L13a is phosphorylated
at Ser77 by a kinase cascade of DAPK and ZIPK (27). L13a phos-
phorylation induces its translocation from the 60S ribosomal sub-
unit to join GAPDH and then the pre-GAIT complex to form the
heterotetrameric GAIT complex that binds GAIT element RNA.
Phosphorylation of EPRS at Ser999 is critical for translational re-
pression activity, as it facilitates the interaction of L13a in the
RNA-bound GAIT complex with a eukaryotic translation initia-
tion factor, eIF4G, of the translation initiation complex at or near
the eIF3-binding site (3, 15). This interaction blocks the recruit-
ment of 40S ribosome-containing preinitiation complex, thereby
inhibiting translation of GAIT element-bearing mRNA.
To date, the GAIT system has been investigated in detail in
human cells only. To begin to understand how widespread the
GAIT system is in vertebrates, we have investigated its presence
and function in mouse myeloid cells. Mice have small genetic
differences compared to humans, with only about 300 unique
genes (23). Moreover, the primary sequences of the four human
GAIT proteins are highly conserved in mice. Mice can be geneti-
callymanipulated and thus are oft-usedmodels of human disease.
Not surprisingly, mouse models are imperfect and differ from
humans in several fundamental processes, including inflamma-
tion. For example, several inflammation-responsive genes in hu-
mans, such as the genes for interleukin-8 (IL-8) and monocyte
chemoattractant protein 4 (MCP4), are absent in mice (23).
Marked differences between mouse and human intestinal immu-
nity have also been observed (9).Differences between humans and
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mice in both innate and acquired immunity are not surprising
because the two species diverged about 65 million to 75 million
years ago and inhabit very different environments with markedly
dissimilar pathogenic challenges (23, 33).
Previous work showed that cytosolic extracts from IFN--ac-
tivated mouse macrophages inhibit in vitro translation of a GAIT
element-containing reporter, suggesting a functional GAIT path-
way inmurinemacrophages (34). To unambiguously establish the
activity of the GAIT pathway, its regulation, and the identity of its
constituents, we investigated the GAIT system in murine macro-
phages. Here we report that IFN- activates GAIT-mediated
translational silencing in mouse macrophages, with important
similarities to and unexpected differences from activation in hu-
man macrophages. Unlike that in humans, the GAIT complex in
mice is heterotrimeric and contains EPRS phosphorylated at
Ser999 but not at Ser886, Ser77-phosphorylated L13a, and GAPDH,
but it is devoid of NSAP1.
MATERIALS AND METHODS
Reagents. Affinity-purified antibodies against human peptides contain-
ing EPRS Ser886 and Ser999 phosphorylation sites, EPRS, and ribosomal
protein L13a were obtained as described previously (3, 21, 33). Small
interfering RNAs (siRNAs) targeting DAPK, ZIPK, and Cdk5 were from
Santa Cruz. Flag-tagged human and mouse EPRS linker (Pro683 to
Asn1023) and full-length L13a cDNA constructs were generated by cloning
into pcDNA3 expression vector (3, 14). Point mutations at Ser886 and
Ser999 in EPRS and Ser77 in L13a to either Ala or Asp were introduced
using primers bearing the desired mutation and a site-directed mutagen-
esis system from Invitrogen. Purified recombinant human NSAP1 and
phosphorylated L13a were as described previously (13). Human GAPDH
was purchased from Sigma (St. Louis, MO). Recombinant, His-tagged
human and mouse EPRS linker proteins (wild type and mutants) were
cloned in pET 30 expression vector and purified (3, 14). Kinase inhibitors
were purchased from EMD (Darmstadt, Germany).
Cell culture.Human U937 monocytic cells, HEK293 embryonic kid-
ney cells, andmouse J774A.1 and RAW264.7macrophages were from the
ATCC (Manassas, VA). U937 cells were cultured in RPMI 1640 medium
containing 10% fetal bovine serum (FBS). Mouse J774A.1, RAW 264.7,
and HEK293 cells were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) with 10% FBS. Bone marrow-derived macrophages (BMM)
were isolated from 8-week-old C57BL6/J mice by flushing themarrows of
femurs and tibias and cultured for 6 days in RPMI 1640medium contain-
ing 10% FBS and 20% L929 cell-conditioned medium. Cells (1  107)
were treated with human or mouse IFN- (500 U/ml; R&D Systems) for
up to 24 h (21). Cell lysates were prepared in Phosphosafe extraction
buffer (Novagen) supplemented with protease inhibitor cocktail.
Cell transfection. Cells were transiently transfected with plasmid
DNAs or siRNAs) using AmaxaNucleofector kit V (Lonza, Cologne, Ger-
many). Transfected cells were immediately transferred to prewarmed
Opti-MEM medium for 6 h and then to RPMI 1640 medium containing
10% FBS for 18 to 24 h.
RNA electrophoretic mobility shift assay (EMSA). -32P-labeled Cp
GAIT element probe was prepared using the oligonucleotide-directed
MEGAshortscript transcription system (Ambion) and custom-synthe-
sized RNA probe templates (Invitrogen) (36). Labeled probe was incu-
batedwith cytosolic lysates fromU937 andRAW264.7 cells. RNA-protein
complexes were resolved by native gel electrophoresis and visualized by
autoradiography. For RNA-protein complex supershift, antibodies
against EPRS, NSAP1, L13a, and GAPDH were preincubated with cyto-
solic extracts for 30 min at 4°C before incubation with labeled probe.
In vitro translation and reconstitution assays. T7 gene 10 and lucif-
erase-Cp 3= UTR GAIT element (Luc-Cp GAIT) reporter mRNAs were
prepared using the mMESSAGEmMACHINE kit (Ambion) as described
previously (13). Gel-purified, capped poly(A) template RNAs were trans-
lated in a rabbit reticulocyte lysate (RRL) system (Promega) in the pres-
ence of [35S]Met. Translated reactions were resolved by SDS-PAGE and
autoradiography. For in vitro reconstitution of GAIT system activity, the
complex was reconstituted by incubating 5 pmol each of purified GAIT
constituent proteins NSAP1, GAPDH, phosphorylated L13a, and EPRS
linker proteins. The effect of reconstituted GAIT complex on in vitro
translation of reporter mRNAs was determined using wheat germ extract
and [35S]Met.
In vitro phosphorylation and Cdk5 activity assay. Purified His-
tagged EPRS linker protein permitting Ser886 and Ser999 phosphorylation
was phosphorylated in vitro by incubation with cell lysate and 5 Ci of
[-32P]ATP (Perkin-Elmer) in kinase assay buffer (50 mM Tris-HCl [pH
7.6], 1 mM dithiothreitol, 10 mMMgCl2, 1 mM CaCl2, and phosphatase
inhibitor cocktail) (2, 3). For Cdk5 activity assay, immunoprecipitates
obtained by incubation with anti-Cdk5 antibody were used to phosphor-
ylate QRRDR886SPTRNREPA derived from human EPRS linker peptide
as described above. 32P incorporation into peptide was determined by
spotting equal volumes on phosphocellulose P-81 paper and scintillation
counting.
32P-labeling experiments. U937 and RAW 264.7 cells were cultured
in phosphate-free RPMI 1640 medium and incubated with IFN- for 2 h
and then with [32P]orthophosphate (500 Ci; Perkin-Elmer, Boston,
MA) for 24 h. The 32P-labeled cells were lysed in Phosphosafe extraction
buffer (Novagen, Darmstadt, Germany) and immunoprecipitated with
anti-EPRS antibody conjugated to protein A-Sepharose (Sigma, St. Louis,
MO).
Protein-protein interaction by coimmunoprecipitation.Cell lysates
(1 mg) were immunoprecipitated by incubation with antibody cross-
linked to protein A-Sepharose or agarose in detergent-free immunopre-
cipitation buffer (50 mM Tris-HCl [pH 7.6], 150 mM NaCl, EDTA-free
protease, and phosphatase inhibitor cocktail) as described previously (3).
The beads were washed three times in the same buffer, eluted, and ana-
lyzed by SDS-PAGE and immunoblotting.
RESULTS
GAIT system silences VEGF-A expression in mouse macro-
phages. We determined the IFN--regulated expression of
VEGF-A, which is a human GAIT target, in RAW 264.7 cells, and
in bone marrow-derived macrophages (BMM) isolated from fe-
murs and tibias of C57BL6/J mice. VEGF-A protein in lysates was
markedly induced in both cell types after 8 h of IFN- treatment
(Fig. 1A). After 24 h, VEGF-A returned to a near-basal level de-
spite abundant VEGF-A mRNA, consistent with translational si-
lencing by theGAIT system (33, 34). To verify the role of theGAIT
pathway, two key activation events were inhibited using specific
siRNAs. Inhibition of either ZIPK or Cdk5, responsible for L13a
and EPRS phosphorylation, respectively, caused sustained expres-
sion of VEGF-A (Fig. 1B). To establish the role of the 3= UTR
GAIT element in the observed translational silencing, we deter-
mined binding of the mouse GAIT complex to the GAIT element
by RNA electrophoretic mobility shift assay using 32P-labeled Cp
GAIT RNA element as a probe. As reported previously (26), ly-
sates from human U937 cells treated with IFN- for 24 h shifted
the GAIT element probe (Fig. 1C). Unexpectedly, both 8- and
24-h lysates from mouse RAW 264.7 cells bound the GAIT ele-
ment. Finally, we determined whether lysates from IFN--treated
cells could inhibit in vitro translation of a luciferase reporter tran-
script containing the human ceruloplasmin (Cp) 3= UTR GAIT
element (Luc-Cp GAIT). As previously observed, 24-h lysates
from human U937 monocytic cells repressed translation of the
Luc-Cp GAIT transcript without affecting the T7 gene 10 control
transcript lacking the GAIT element (Fig. 1D). Likewise, 24-h ly-
sates from mouse BMM, RAW 264.7, and J774A.1 macrophages,
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but not from the nonmacrophage HEK293 cells, were inhibitory.
These results provide compelling evidence for GAIT-mediated
regulation of gene expression in mouse macrophages. However,
the binding of the mouse GAIT complex to target elements after 8
h of IFN- treatment suggests that the GAIT system is not identi-
cal to that in human cells.
DAPK and ZIPK mediate L13a phosphorylation at Ser77 in
mousemacrophages. IFN--induced phosphorylation of L13a at
Ser77 is critical for GAIT pathway activation in humanmonocytes
(3, 27). The human Ser77 phosphorylation site in L13a is con-
served in other mammalian species, including mice (Fig. 2A). To
investigate temporal phosphorylation of L13a in mouse macro-
phages, RAW 264.7 cell lysates were prepared after 8 h of IFN-
treatment and then at 4-h intervals for up to 24 h, and they were
immunoblotted with anti-phospho-Ser antibody after immuno-
precipitation with anti-L13a antibody (Fig. 2B). L13a phosphor-
ylation was induced between 12 and 16 h post-IFN- treatment
and remained phosphorylated until 24 h, as shown for human
monocytic cells (27). To determine if murine L13a is phosphory-
lated at Ser77, phosphorylation-defective Ser77-to-Ala (S77A)mu-
tant pcDNA3-Flag-mouse L13a was transiently transfected in
U937 and RAW 264.7 cells (Fig. 2C). L13a phosphorylation was
determined by immunoprecipitation with anti-Flag antibody and
immunoblotting with anti-phospho-Ser antibody. IFN--in-
duced phosphorylation of human and mouse L13a bearing the
S77A mutation was completely abrogated in both human and
mouse cells (Fig. 2C). To determine if mouse L13a is phosphory-
lated by the kinase cascade active in human cells, RAW 264.7 cells
were transfected with siRNAs targeting DAPK and ZIPK. IFN--
induced L13a phosphorylation was assessed with anti-phospho-
Ser antibody following immunoprecipitation with anti-L13a an-
tibody. L13a phosphorylation was completely inhibited in DAPK
(Fig. 2D, left) and ZIPK (Fig. 2D, right) knockdown cells. To show
that murine L13a is in the GAIT complex, RAW 264.7 and U937
cells were treated with IFN- for 24 h, metabolically labeled with
32P, and subjected to immunoprecipitation with anti-EPRS anti-
body. Immunoblot analysis with anti-L13a antibody revealed
stimulus-dependent interaction of murine L13a with EPRS (Fig.
2E, top two blots). Autoradiography revealed stimulus-dependent
radiolabeled bands consistent in size with phospho-L13a and
FIG 1 IFN- activates the GAIT system in murine macrophages. (A) RAW 264.7 cells and BMM from wild-type C57BL6/J mice were treated with IFN- for 8
and 24 h. Cell lysates were immunoblotted (IB) using anti-VEGF-A and anti--actin antibodies. VEGF-A and -actin mRNA was determined by reverse
transcription-PCR (RT-PCR) of total cellular RNA. (B) RAW 264.7 cells were transfected with siRNAs against ZIPK and Cdk5, and control scrambled siRNAs,
and incubated with IFN- for up to 24 h. Lysates were immunoblotted as shown. (C) Analysis of protein binding to the CpGAIT element. Cytosolic lysates from
IFN--treated U937 and RAW 264.7 cells were incubated with a 32P-labeled Cp GAIT element RNA probe, and binding was determined by EMSA. (D) In vitro
translation. Cells were incubated with IFN- and lysates added to rabbit reticulocyte lysates in the presence of capped, polyadenylated luciferase (Luc) reporter
RNA bearing the 3= UTR Cp GAIT element and T7 gene 10 control RNA and [35S]Met. Luc translation was quantified by densitometry, normalized by T7 gene
10, and expressed as a percentage of the control (mean SEM; n 3 experiments).
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-EPRS in both murine and human cells (Fig. 2E, bottom). These
experiments indicate that the mechanism of IFN- activation of
L13a in murine macrophages is essentially identical to that ob-
served in human myeloid cells.
EPRS is singly phosphorylated at Ser999 in EPRS in murine
macrophages. IFN--induces dual serine phosphorylation of
Ser886 and Ser999 in human EPRS, coordinating key events in as-
sembly and activity of the GAIT complex (3). Surprisingly, the
Ser999 phosphosite, but not the Ser886 site, is conserved in mouse
EPRS, suggesting a modified mechanism of GAIT activation (Fig.
3A). To investigate sites of murine EPRS phosphorylation exper-
imentally, RAW 264.7 cells were treated with IFN- and analyzed
by phospho-specific antibodies. Stimulus-dependent phosphory-
lation was detected at both sites in human cells; phosphorylation
of only Ser999 was observed in mouse cells (Fig. 3B). To verify this
result, pcDNA3-Flag-EPRS linkers (mouse and human) bearing
phosphosite Ser-to-Ala mutations were transiently transfected in
U937 and RAW 264.7 cells. After induction with IFN-, EPRS
linker phosphorylation was determined by immunoprecipitation
with anti-Flag antibody followed by detection with anti-phospho-
Ser antibody. Single-site mutation of Ser999 to Ala (S999A) com-
pletely abrogated mouse EPRS linker phosphorylation but ap-
proximately halved phosphorylation of the human linker, in
which phosphorylation was completely blocked only when both
phosphosites were mutated (Fig. 3C). Similar results were seen
following transfection of either human or mouse cells. These re-
sults show that in contrast to the human protein, only a single site
in mouse EPRS linker (Ser999) is phosphorylated following IFN-
stimulus.
The upstream kinase(s) required for phosphorylation of
mouse EPRS Ser999 was investigated. In human cells, Cdk5 (with
its activation partner, p35) has dual activity in EPRS activation; it
is the proximal kinase that phosphorylates Ser886 and is an up-
stream component of a cascade responsible for Ser999 phosphor-
ylation. In the absence of Ser886 phosphorylation by Cdk5/p35 in
the mouse, it is conceivable that this kinase likewise is not a com-
ponent of the cascade required for phosphorylation of mouse
Ser999. To begin to investigate species differences (or similarities),
FIG 2 IFN- induces DAPK-ZIPK-mediated L13a phosphorylation at Ser77 in mouse macrophages. (A) Multiple-sequence alignment of mammalian L13a
protein. The conserved Ser77 phosphorylation site is shaded and the kinase recognition motif underlined. (B) Delayed induction of L13a phosphorylation in
mouse macrophages. Lysates from IFN--treated RAW 264.7 cells were immunoprecipitated with anti-L13a antibody and phosphorylation determined by
immunoblotting with anti-phospho-Ser (P-Ser) antibody. (C) Mouse L13a is phosphorylated on Ser77. Human and murine Flag-tagged, wild-type (WT) and
Ser77-to-Ala (S77A)mutant L13a proteins were transfected in U937 and RAW264.7 cells and treated with IFN- for 16 h. Lysates were immunoprecipitated (IP)
with anti-Flag antibody, followed by immunoblotting with anti-P-Ser antibody. (D) DAPK and ZIPK knockdown prevents L13a phosphorylation. RAW 264.7
cells were transfected with siRNAs against DAPK (left) and ZIPK (right) or scrambled control (Cont.) siRNAs. Lysates were immunoprecipitated with anti-L13a
antibody, and phosphorylation was determined using anti-P-Ser antibody. (E) Mouse L13a translocates to the GAIT complex. RAW 264.7 and U937 cells were
treated with IFN- for 24 h in the presence of [32P]orthophosphate. Lysates were subjected to immunoprecipitation with anti-EPRS antibody and analyzed by
immunoblotting with antibodies against EPRS and L13a (top two blots) and by autoradiography (bottom).
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FIG 3 IFN- induces single-site EPRS phosphorylation at Ser999. (A) Multiple-sequence alignment of mammalian EPRS protein. Conserved Ser886 and Ser999
phosphorylation sites are shaded, and the kinase recognitionmotif around human Ser886 is underlined. (B) EPRS is phosphorylated at Ser999 in RAW264.7 cells.
Lysates from IFN--treated cells were probed with phospho-specific antibodies and with anti-EPRS antibody as a loading control. (C) Ser999 is the only EPRS
linker site phosphorylated inmurine cells. Human andmouse pcDNA3-Flag-tagged, wild-type as well as single and double Ser-to-Alamutant EPRS linkers were
transfected into U937 and RAW264.7 cells. Cells were treated with IFN- for 4 h, and lysates were immunoprecipitated with anti-Flag antibody and probed with
anti-Flag and anti-P-Ser antibodies. (D) IFN--activatedmousemacrophages phosphorylate human EPRS at both Ser886 and Ser999. Lysates from IFN--treated
cells were used to in vitro phosphorylate recombinant EPRS linkers bearing Ser999-to-Ala and Ser886-to-Ala mutations in the presence of [-32P]ATP. (E) IFN-
induces Cdk5 activity in mouse macrophages. U937 and RAW 264.7 cells were treated with IFN- for 4 h, and the lysates were immunoprecipitated with
anti-Cdk5 antibody and used for in vitro phosphorylation of a Ser886-containing EPRS peptide (QRRDR886SPTRNREPA) substrate (mean  SEM; n  4
experiments). (F) Cdk5 knockdown in mouse macrophages blocks EPRS phosphorylation. RAW 264.7 cells were transfected with siRNA against Cdk5 or
scrambled control siRNA. Lysates were subjected to immunoblot analysis with antibody against P-EPRS-Ser999. (G) A Cdk5-dependent AGC group kinase
phosphorylates Ser999. RAW 264.7 cells were incubated with IFN- for 0.5 h and then with specific kinase inhibitors for an additional 3.5 h. Pro-directed kinase
group inhibitors were roscovitine (10 M) and olomoucine (50 M); AGC kinase group inhibitors were H-7 (10 M), H-8 (10 M), staurosporine (20 nM),
rottlerin (100 M), LY294002 (2.5 M), Akt inhibitor VIII (2.5 M), and rapamycin (10 nM). Lysates were analyzed by immunoblotting as indicated. (H)
Schematic of IFN--induced EPRS phosphorylation in human and mouse macrophages.
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we tested whether mouse cell lysates could in vitro phosphorylate
human EPRS linkers bearing mutations permitting single-site
phosphorylation. Lysates from IFN--treated RAW 264.7 cells
efficiently phosphorylated both Ser886 and Ser999 sites (Fig. 3D).
To test Cdk5 activation inmousemacrophages directly, Cdk5 was
immunoprecipitated from lysates from IFN--treated cells and
used to in vitro phosphorylate the human EPRS peptide substrate
containing the Ser886 site. Cdk5 from RAW 264.7 and U937 cells
phosphorylated the peptide substrate, confirmingCdk5 activation
in mouse macrophages (Fig. 3E). siRNA-mediated knockdown of
Cdk5 completely inhibited Ser999 phosphorylation (Fig. 3F). The
effect of group-specific pharmacological inhibitors was investi-
gated. Agents targeting Pro-directed kinases, including Cdk5, sig-
nificantly inhibited IFN--stimulated phosphorylation of EPRS
Ser999 (Fig. 3G), as observed in human cells (3). Inhibition of
Ser999 phosphorylation by H7, H8, and rapamycin suggests a pos-
sible role for a ribosomal S6 kinase family member or a cyclic-
nucleotide-dependent protein kinase (protein kinase A [PKA],
PKG, etc.). Akt inhibitor VIII, the phosphatidylinositol 3-kinase
(PI3K) inhibitor LY294002, and the PKC inhibitor rottlerin were
ineffective. Together these results suggest that IFN--inducible
Cdk5/p35 activation is required for EPRS phosphorylation in
both human andmousemacrophages (Fig. 3H). In humans, IFN-
-activated Cdk5/p35 directly phosphorylates Ser886 and indi-
rectly phosphorylates Ser999 via activation of anAGCkinasemem-
ber. In contrast, IFN--activated Cdk5/p35 is required only as an
upstream activator of the AGC kinase that phosphorylates Ser999
in mouse macrophages.
Phosphorylation at both Ser886 and Ser999 is required for EPRS
release from its residence in the aminoacyl-tRNAmultisynthetase
complex (MSC) in human monocytes (3). We investigated
whether phosphorylation of the sole Ser999 site was sufficient to
induce release of mouse EPRS from the MSC. Lysates from IFN-
-treated RAW 264.7 cells were immunoprecipitated with anti-
EPRS antibody and immunoblotted with antibodies against the
MSC constituent, aminoacyl-tRNA synthetase-interacting multi-
functional protein 3 (AIMP3/p18), and the GAIT complex con-
stituent, L13a. Substantially reduced interaction of EPRS with
AIMP3/p18 and increased association with L13a were observed in
IFN--treated cells, suggesting that single-site phosphorylation at
Ser999 is sufficient for translocation from the MSC to GAIT com-
plex (Fig. 4).
Mouse GAIT complex lacks NSAP1. The differential binding
characteristics of the mouse and human GAIT complexes (Fig.
1C)might be attributable to dissimilar protein components. Con-
stituents of the mouse GAIT complex were determined by RNA-
EMSA supershift analysis using 32P-labeled Cp GAIT RNA ele-
ment as a probe. After 24 h of IFN- treatment, EPRS, L13a, and
GAPDH could bind the GAIT element, but unlike in human cells,
NSAP1 did not bind (Fig. 5A). A second species difference was
observed, namely, that mouse EPRS binds the GAIT element at 8
h, whereas we previously showed that no human GAIT complex
components bind GAIT element RNA until at least 16 h of IFN-
treatment (21, 27). These results suggest that NSAP1 is not a con-
stituent of the GAIT complex in mouse myeloid cells, a finding
consistent with the absence of the EPRS Ser886 phosphosite re-
quired for NSAP1 binding in human cells.
Immunoblot analysis of cytosolic lysates fromRAW264.7 cells
showed that the four humanGAIT complex constituents are pres-
ent inmouse cells and unaffected by IFN- treatment (Fig. 5B, left
blots). Immunoprecipitation with anti-EPRS antibody verified
that unlike in human cells, mouse NSAP1 is not present in a pre-
GAIT complex formed at 8 h of IFN- treatment, nor is it in a
mature GAIT complex formed after 24 h (Fig. 5B, center blots).
Immunoprecipitation with anti-NSAP1 antibody confirmed that
NSAP1 does not bind any of the GAIT complex proteins inmouse
myeloid cells (Fig. 5B, right blots).
Reconstitution of murine GAIT system requires single-site
EPRS phosphorylation and not NSAP1. Ser886- and Ser999-phos-
phorylated EPRS and Ser77-phosphorylated L13a (P-L13a) are the
key stimulus-dependent constituents of the functional GAIT ri-
bonucleoprotein (RNP) complex in humans (Fig. 6A, top). Pre-
viously, using phospho-mimetic human EPRS linker, we recon-
stituted GAIT system activity with single-site phosphorylation at
Ser999 (3). Because NSAP1 is not present in themouse GAIT com-
plex, we investigated its requirement for activity in the human
GAIT complex. The GAIT complex was reconstituted by incubat-
ing wild-type, phosphorylated wild-type, and Ser-to-Asp mutant
human EPRS linkers with P-L13a in the presence and absence of
GAPDH and NSAP1. Activity of the reconstituted GAIT complex
was determined by in vitro translation of a Luc-Cp-GAIT element
reporter, and control T7 gene 10 RNA, in a wheat germ extract in
the presence of [35S]Met. Translation repression of the GAIT ele-
ment-bearing reporter was observed when NSAP1, P-L13a, and
GAPDH were reconstituted with a phosphorylated, wild-type
EPRS linker or single S999D or double S886D/S999D phospho-
mimetic linkers, confirming the requirement for Ser999 phosphor-
ylation for assembly and activity of human GAIT complex (Fig.
6B). Reconstitution of the S999D EPRS linker with P-L13a and
GAPDH, but not NSAP1, also inhibited reporter expression, in-
dicating thatNSAP1 is not an essential constituent of a repression-
competent human GAIT complex. A similar reconstitution was
done using the mouse EPRS linker. Purified, recombinant wild-
type mouse EPRS linker and S999A (unmodified and kinase
treated) and S999D mutant linkers were reconstituted with
P-L13a and GAPDH. Comparable translational silencing of a
GAIT element-bearing reporter was observed in the absence or
presence of NSAP1 (Fig. 6C). These studies verify the function of
FIG4 Ser999 phosphorylation induces EPRS translocation fromMSC toGAIT
complex. Lysates from IFN--treated RAW 264.7 cells were immunoprecipi-
tated with anti-EPRS antibody and subjected to immunoblot analysis with
anti-AIMP3/p18 and anti-L13a antibodies to determine association withMSC
and GAIT complex, respectively. Phospho-specific antibodies were used to
determine EPRS phosphorylation.
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the NSAP1-deficient, heterotrimeric GAIT complex in mice (Fig.
6A, bottom).
DISCUSSION
Our results reveal important similarities and unexpected differ-
ences between the IFN--induced GAIT systems in human and
mouse myeloid cells. The human GAIT system is induced by two-
site Ser phosphorylation in EPRS at Ser886 by Cdk5 and Ser999 by a
cascade of Cdk5 and an unidentified AGC kinase (1–3). EPRS
phosphorylation is followed by release from the MSC and inter-
acts with NSAP1 to form the dimeric pre-GAIT complex (Fig. 7,
top). Subsequent phosphorylation of L13a at Ser77 by the DAPK-
ZIPK cascade releases it from the 60S ribosomal subunit. Phos-
phorylated L13a binds GAPDH, and together they bind the pre-
GAIT complex to form the heterotetrameric GAIT complex. The
GAIT complex binds the 3= UTR GAIT element in the target
mRNA, and by a mechanism dependent on end-to-end interac-
tions of themRNA, P-L13a inGAIT complex interacts with eIF4G
of the translation initiation complex, thereby blocking recruit-
ment of the small ribosomal subunit and translation initiation. In
mice, IFN- similarly activates theGAIT systemvia induced phos-
phorylation of EPRS and L13a (Fig. 7, bottom). However, mouse
EPRS is subject to single-site phosphorylation at Ser999 only. De-
spite the specific loss of the Ser886 phosphosite inmouse EPRS, the
Ser886 kinase Cdk5 is required for activation of the AGC kinase
that phosphorylates Ser999. The lack of Ser886 phosphorylation
prevents interaction with NSAP1 but permits release of EPRS
from theMSC and joining with L13a and GAPDH to form a func-
tional, heterotrimeric GAIT complex that binds GAIT element in
target mRNAs and represses translation.
The absence of NSAP1 from the murine GAIT complex indi-
cates that its function is secondary rather than essential in the
FIG 5 Mouse GAIT complex lacks NSAP1. (A) RNA EMSA supershift investigation of binding ofmouse GAIT complex proteins to GAIT element. Lysates from
IFN--treated RAW 264.7 cells were incubated with antibodies against GAIT complex constituents and then with a 32P-labeled Cp GAIT element RNA probe.
(B) Lysates from IFN--treated U937 and RAW 264.7 cells were immunoblotted with antibodies against human GAIT complex constituents (left). Lysates were
immunoprecipitated with anti-EPRS (middle) and anti-NSAP1 (right) antibodies and subjected to immunoblot analysis as indicated.
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human system. This concept was verified experimentally by the in
vitro reconstitution of GAIT activity by the human (and mouse)
EPRS linker with GAPDH and P-L13a (Fig. 6B and C). The func-
tion of NSAP1 in the human GAIT system has been investigated
before (3, 13). NSAP1 binding to human EPRS requires phos-
phorylation of Ser886 in the spacer between the second (R2) and
third (R3) of the three helix-turn-helix WHEP repeats (named
after the aminoacyl-tRNA synthetases that contain them, i.e., Trp-
(W)RS, His(H)RS, and EPRS [12, 41]) that populate the human
and mouse EPRS linker domains (Fig. 6A). NSAP1 binding to
human EPRS blocks the binding of GAIT element-bearingmRNA
to the first (R1) and second (R2) WHEP repeats. The NSAP1-
mediated inhibition is reversed by the subsequent interaction of
P-L13a and GAPDH to EPRS that induces a conformational shift
in the linker and exposes theRNAbinding sites of EPRS. In viewof
the nearly 16-h residence in the cell beforematuration as theGAIT
complex, it is possible, if not likely, that the human pre-GAIT
complex exhibits a GAIT-independent function. It is also possible
that the human NSAP1-containing, pre-GAIT complex binds
non-GAIT mRNA targets and affects a different function, for ex-
ample, mRNA stability. This possibility is supported by reports of
multiple RNA-related regulatory functions of NSAP1, also known
as heterogeneous nuclear ribonucleoprotein (hnRNP) Q or syn-
aptotagmin-binding cytoplasmic RNA interacting protein
FIG 6 NSAP1 is not essential for reconstitution of GAIT complex function.
(A) Schematic of human heterotetrameric (top) and mouse heterotrimeric
(bottom) GAIT RNP; (B) reconstitution of GAIT function with human EPRS
linker. His-tagged, wild-type (WT), and phospho-mimetic (Ser-to-Asp,
S-to-D) human EPRS linker proteins were generated. Phosphorylated WT
(P-WT) linker was generated by incubation with IFN--activated cell lysate
and repurified by Ni affinity chromatography. Linker proteins were incubated
with other GAIT constituents as indicated and added towheat germ extract for
in vitro translation of luciferase (Luc)-Cp-GAIT element and T7 gene 10 re-
porters. (C) Reconstitution of GAIT function with mouse EPRS linker. His-
tagged WT, P-WT, phospho-defective (S999A), phosphorylated S999A
(P-S999A; generated by incubation with IFN--activated cell lysate and repu-
rified) and phospho-mimetic (S999D)mouse EPRS linker proteins were incu-
bated other GAIT constituents and used in the in vitro experiment.
FIG 7 Comparison of human and mouse GAIT systems. Human heterotetra-
meric (top) and mouse heterotrimeric (bottom) GAIT complexes are shown.
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(SYNCRIP), including editing, splicing, stabilization, transport,
surveillance by nonsense-mediated mRNA decay, and internal ri-
bosome entry site (IRES)-dependent translation (4–6, 11, 17, 25,
29). Like the human pre-GAIT complex, mouse phospho-EPRS
might exhibit GAIT-independent functions until joined by other
constituents of the functional GAIT complex. Two important
structural and functional differences distinguish the released mu-
rine phospho-EPRS from its human counterpart. First, the ab-
sence of NSAP1 binding to murine P-EPRS eliminates any role of
the former in regulating the RNA-binding property of the latter.
Second, unlike the human pre-GAIT complex, free murine P-
EPRS can bind GAIT element-bearing target mRNAs, but it is
unable to silence translation until P-L13a and GAPDH join to
form the active trimeric complex. Free murine phospho-EPRS
therefore could influence GAITmRNA targets by GAIT-indepen-
dent mechanisms, for example, by influencing mRNA stability or
by binding to other, non-GAIT translational control complexes.
The absence of the Ser886 phosphorylation site in mice is not
particularly exceptional. Global alignment of orthologs of func-
tional phosphorylation sites indicates that about 80%of phospho-
Ser and -Thr sites are conserved in mammals, suggesting that
phosphorylation sites are frequently gained or lost during evolu-
tion, most likely to direct species-specific activities (10). Conser-
vation of the Ser886 phosphosite in primates, rat, horse, and opos-
sum (an early-appearing placental mammal) suggests that its
absence in mice is due to a species-specific loss (Fig. 3A). Several
differences between mouse and human phosphosites have been
investigated. In one example, the Thr157 phosphosite in human
p27kip1 is not conserved inmice (28). Phosphorylation at this site
has been implicated in protein-protein interactions and nuclear
localization and is critical for regulation of cell cycle progression
(24, 40, 42). Likewise, phosphorylation of Ser216 in the dual-spec-
ificity protein phosphatase Cdc25C is essential for G2 arrest after
DNA damage but is absent in mice (19, 30).
Expression patterns and functions of the vast majority of genes
are common to humans andmice (16). However, 65million to 75
million years of evolutionary divergence have introduced signifi-
cant functional differences in both orthologous and paralogous
genes in the two species (23). In fact, mitochondrial DNAs from
museum skins of white-footed mice living in the same location
from 1855 to the present exhibit surprisingly rapid microevolu-
tion (31).Multiple species-specific differences related to immune-
or inflammation-related responses have been reported, driven in
part by challenges towidely different pathogens in distinct ecolog-
ical niches (23, 39). Several examples involve differential re-
sponses to specific agonists and inflammatory challenges. For ex-
ample, inducible nitric oxide synthase (iNOS) is induced by IFN-
and lipopolysaccharide in mouse but not in human macrophages
(38). Also, inmice a higher concentration of endotoxin is required
to induce an acute inflammatory response, e.g., induction of
plasma interleukin-6 (7). More specifically, Toll-like receptors in
murine macrophages trigger direct antimicrobial activity against
intracellular bacteria compared to the indirect, vitamin D-depen-
dent activation in human monocytes/macrophages (18). Impor-
tant constitutive, stimulus-independent differences between the
species have been reported. For example, human blood is neutro-
phil rich, whereas mouse blood is lymphocyte rich (23); more-
over, only human neutrophils produce defensins (23, 35). These
species-specific differences in inflammatory responses are not just
of evolutionary interest; they also profoundly affect the clinical
applicability of therapeutic agents successfully tested in mouse
models, e.g., in septic shock (20, 32, 39). Thus, it is neither excep-
tional nor surprising that the protein constituents and activation
mechanisms of the GAIT system differ in mouse and human my-
eloid cells. It is also possible, if not likely, that the mRNA targets
differ between species. Although VEGF-A is targeted in both spe-
cies, secondary-structure analysis byMfold suggests that theGAIT
element is not conserved in mouse Cp (33). Our validation and
characterization of themurineGAIT system lay a solid foundation
for future in vivo studies. However, our results certainly recom-
mend a cautious approach in extrapolating to humans the find-
ings from genetic mouse models of defective or absent GAIT sys-
tem components.
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